Montauk Renewables, Inc. · NASDAQ:MNTK
Montauk Renewables — Q2 2024 Earnings Presentation
16 slides from Montauk Renewables's earnings presentation, Aug 8, 2024
Slide 1: Investor Presentation – Second Quarter 2024 Results
Investor Presentation SECOND QUARTER 2024 RESULTS AUGUST 8, 2024
Slide 2: Cautionary Statement Regarding Forward-Looking and non-GAAP Financial Information
Cautionary Statement Regarding Forward-Looking and non-GAAP Financial Information This presentation contains “forward-looking statements” within the meaning of U.S. federal securities laws. Such statements include, among others, those we make relating to our estimated and projected financial conditi
Slide 3: Financial Performance – Income Statement
Financial Performance Income Statement 3
Slide 4: Operational Results – Quarter Ended June 30, 2024
Operational Results – Quarter Ended June 30, 2024 (in thousands, unless otherwise indicated) All comparisons are between the second quarter ended June 30, 2024 and the second quarter ended June 30, 2023, unless otherwise indicated Renewable Natural Gas (“RNG”) Metrics – 49 MMBtu decreased production
Slide 5: Operational Performance – Operating Metrics
Operational Performance Operating Metrics 5
Slide 6: Financial Performance – Balance Sheet
Financial Performance Balance Sheet 6
Slide 7: Cash Flow
Cash Flow (in thousands, unless otherwise indicated) Operating items affecting net income include: – $(2,871) adjustments to working capital and other assets and liabilities – $4,339 accounting for stock-based compensation Investing activities highlights include: – $19,001 capital expenditures for M
Slide 8: Business Development – RINs Generated but Unsold
Business Development RINs Generated but Unsold (in thousands, unless otherwise indicated) Second Quarter 2024 Highlights – Strategic decision to not commit to transfer all available D3 RINs generated and available for transfer from second quarter 2024 RNG production – Approximately 4,707 RINs in inv
Slide 9: Capital Development Summary
Business Development Capital Development Summary (in thousands, unless otherwise indicated) The following summarizes our ongoing development growth plans expected capacity contribution, anticipated commencement of operations, and capital expenditure estimate, respectively, excluding the Montauk Ag R
Slide 10: Pico Feedstock Amendment
Business Development Pico Feedstock Amendment (in thousands, unless otherwise indicated) Second Quarter 2024 Highlights – Processing all available feedstock – Produced 39% more MMBtu more in first half of 2024 compared to first half of 2023 – Expect dairy to deliver final feedstock increase during 2
Slide 11: RNG Facility Developments – Second Quarter 2024 Highlights
Business Development RNG Facility Developments – Second Quarter 2024 Highlights Second Apex RNG Facility: – Currently expect commercial operations in second quarter of 2025 Blue Granite RNG Facility: – Continue to review various alternatives related to interconnection opportunities – Expect commerci
Slide 12: Montauk Ag Renewables
Business Development Montauk Ag Renewables Second Quarter 2024 Highlights – Commissioned the relocated Magnolia reactor at Turkey, NC processing facility – Completed the majority of the installation of collection process equipment on two farms for which we have feedstock agreements – In August 2024,
Slide 13: Carbon Dioxide Beneficial Use Opportunity
Business Development Carbon Dioxide Beneficial Use Opportunity (in thousands, unless otherwise indicated) Second Quarter 2024 Highlights – Completed initial site surveys related to biogenic carbon dioxide (“CO2”) processing equipment – Received the first site plans from European Energy (“EENA”) – Si
Slide 14: Strategic Growth Opportunity Pipeline
Business Development Strategic Growth Opportunity Pipeline Positioned for continued growth, with on-going evaluation of various strategic opportunities: – Multiple LFG RNG and CNG distribution opportunities in various stages of evaluation – Exploring wastewater treatment to RNG project opportunities
Slide 15: Appendix
Appendix MONTAUK
Slide 16: Non-GAAP Reconciliation – EBITDA and Adjusted EBITDA
Non-GAAP Reconciliation EBITDA and Adjusted EBITDA 16